<DOC>
	<DOCNO>NCT00661011</DOCNO>
	<brief_summary>The purpose study determine radical radiochemotherapy mediastinum lobectomy associate significant long term survival patient initially unresectable stage III NSCLC respond induction chemotherapy residual disease large treat radiotherapy .</brief_summary>
	<brief_title>Lobectomy Mediastinal Radiochemotherapy Unresectable Stage III Non-Small Cell Lung Cancer Responding Induction Chemotherapy</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Vinorelbine</mesh_term>
	<criteria>Histological cytological diagnosis nonsmall cell carcinoma lung Initially stage III NSCLC Pathologically proven N2 N3 disease Any response induction chemotherapy ( whatever regimen administer ) Disease still fully resectable ( extensive mediastinal N disease ) suitable radical radiotherapy ( single field ) induction chemotherapy Lobectomy possible treatment T disease Availability participate detailed followup protocol Informed consent Prior treatment radiotherapy surgery Karnofsky PS &lt; 60 Functional anatomical contraindication mediastinal radiotherapy Functional anatomical contraindication surgical lobectomy A history prior malignant tumour , except nonmelanoma skin cancer situ carcinoma cervix cure malignant tumour ( 5 year diseasefree interval ) Malignant pleural pericardial effusion Neutrophils &lt; 2,000/mmÂ³ Platelet cell &lt; 100,000/mm3 Serum bilirubin &gt; 1.5 mg/100 ml Serum creatinine &gt; 1.5 mg/100 ml and/or creatinine clearance &lt; 60 ml/min Recent myocardial infarction ( le 3 month prior date diagnosis ) Congestive cardiac failure cardiac arrhythmia require medical treatment Uncontrolled infectious disease Hearing loss Symptomatic polyneuropathy Serious medical psychological factor may prevent adherence treatment schedule</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Non-small cell lung carcinoma</keyword>
	<keyword>Concomitant radiochemotherapy</keyword>
	<keyword>Cisplatin</keyword>
	<keyword>Vinorelbine</keyword>
	<keyword>Radiotherapy</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>Unresectable stage III non-small cell lung carcinoma</keyword>
	<keyword>Surgery</keyword>
	<keyword>Unresectable stage III non-small cell lung carcinoma suitable radical radiotherapy objective response induction chemotherapy</keyword>
</DOC>